Management of osteoporosis in the aging male: focus on zoledronic acid.
about
Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone massEfficacy of zoledronic acid in treatment of osteoporosis in men and women-a meta-analysis.Effects of clodronate combined with hydroxyapatite on multi-directional differentiation of mesenchymal stromal cellsClinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinionsCauses, consequences, and treatment of osteoporosis in men.Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged rats
P2860
Management of osteoporosis in the aging male: focus on zoledronic acid.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of osteoporosis in the aging male: focus on zoledronic acid.
@en
Management of osteoporosis in the aging male: focus on zoledronic acid.
@nl
type
label
Management of osteoporosis in the aging male: focus on zoledronic acid.
@en
Management of osteoporosis in the aging male: focus on zoledronic acid.
@nl
prefLabel
Management of osteoporosis in the aging male: focus on zoledronic acid.
@en
Management of osteoporosis in the aging male: focus on zoledronic acid.
@nl
P2860
P356
P1476
Management of osteoporosis in the aging male: focus on zoledronic acid.
@en
P2093
Paul K Piper
Ugis Gruntmanis
P2860
P304
P356
10.2147/CIA.S4295
P407
P577
2009-06-29T00:00:00Z